Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Coronary Stents Market Overview

The coronary stents market size was valued at $4.37 billion in 2023. The market will grow at a CAGR of less than 1% during 2023-2033. Factors such as rapidly changing lifestyles and growing unhealthy diets are leading to increased risk of coronary heart disease, which will drive the market growth in coming years.

A coronary stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The coronary stent system consists of a stent and balloon catheter delivery system.

Coronary Stents Market Outlook, 2023-2033 ($ Billion)

Coronary Stents Market Outlook, 2023-2033 ($ Billion)

Buy the Full Report for More Insights into the Coronary Stents Market Forecast, Download a Free Report Sample

The coronary stents market research report identifies quantitative market trends within cardiovascular devices therapeutic areas. The report offers regional quantitative and qualitative data, highlighting the sales in major markets. The model also provides an in-depth discussion of COVID-19’s effects on the coronary stents market for 2020 and beyond. Furthermore, the report provides coronary stents market share by company that will help in identifying untapped market opportunities.

Market Size (2023) $4.37 billion
CAGR (2023-2033) <1%
Forecast Period 2023-2033
Historical Period 2015-2022
Key Regions
  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South and Central America
Key Segments ·        Coronary Bare Metal Stents (BMS)

·        Coronary Drug Eluting Stents

·        Coronary Covered Stents

·        Coronary Bioabsorbable Stents

Leading Companies ·        Boston Scientific Corp

·        Abbott Laboratories

·        Medtronic Plc

·        Biotronik SE & Co KG

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Coronary Stents Market Segments

The Coronary Stents Market is segmented into Coronary Bare Metal Stents (BMS), Coronary Drug Eluting Stents (DES), Coronary Covered Stents, and Coronary Bioabsorbable Stents (BAS). The DES segment accounted for the largest market share in 2023. The volume of DES devices used is increasing globally due to their superior clinical outcomes compared to other stents.

Coronary drug-eluting stents release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.

Coronary bioabsorbable stents are also known as bioresorbable or biodegradable coronary stents. They are made from the material found in dissolvable sutures known as polylactic acid. The advantage of coronary bioabsorbable stents is that it does not leave any metal body behind, and hence the possibility of late-stent thrombosis and restenosis decreases.

Coronary Stents Market Analysis by Segments, 2023 (%)

Coronary Stents Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Insights into the Coronary Stents Market Segments, Download A Free Report Sample

Regional Analysis of Coronary Stents Market

The key regions in the coronary stents market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. In 2023, the North American coronary stents market was the leading regional segment.

The North American coronary stents market growth is attributed to high demand for DES devices, which are used in more than 95% of PCI cases. The US and Canada will see stable growth in the coronary stent market during the forecast period. Due to a rise in the aging population, the burden of CHD remains high. Additionally, better PCI techniques and tools will allow physicians to treat patients with PCI, thereby increasing the demand for stents.

The US coronary stents market follows regional trends for North America. Factors such as the rising aging population, the reduced need for repeat intervention, and investment in R&D will drive the stenting procedure volume in the US in the coming years.

Coronary Stents Market Analysis by Regions

Coronary Stents Market Analysis by Regions

Buy the Full Report for More Regional Insights into the Coronary Stents Market, Download A Free Report Sample

Coronary Stents Market – Competitive Landscape

In 2023, Boston coronary stents market share was the highest

A few of the leading companies in the coronary stents market are:

  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • Biotronik SE & Co KG
  • Lepu Medical Technology (Beijing) Co Ltd
  • Braun Melsungen AG

To penetrate the market, small companies should develop a generation of bioabsorbable stents that show superior clinical results. The potentially successful smaller companies would make good acquisition targets for large companies looking to enter the bioabsorbable stent market.

Coronary Stents Market Analysis by Companies, 2023 (%)

Coronary Stents Market Analysis by Companies, 2023 (%)

Buy the Full Report to Know More About the Leading Companies In the Coronary Stents Market, Download A Free Report Sample

Coronary Stents Market Dynamics

Drivers: Change in lifestyles, unhealthy diets, and rapid globalization will drive the coronary stents market growth during the forecast period. However, factors such as the high cost of treatment and post-procedural complications of stenting may challenge the market growth.

Future Outlook: Most developed countries have recognized the effectiveness of PCI and stenting procedures to treat AP and MI. The penetration rate for PCI procedures is high, which implies that much of the population that requires treatment is being treated with PCI leading to slower growth. Furthermore, developing countries have potential owing to the presence of a large undiagnosed and untreated population.

Buy the Full Report to Know More About the Coronary Stents Market Dynamics, Download a Free Report Sample

Segments Covered in the Report

Coronary Stents Segments Outlook (Value, $ Billion, 2015-2033)

  • Coronary Bare Metal Stents
  • Coronary Drug Eluting Stents
  • Coronary Covered Stents
  • Coronary Bioabsorbable Stents

Coronary Stents Regional Outlook (Value, $ Billion, 2015-2033)

  • North America
  • Europe
  • Asia Pacific
  • South Central America
  • Middle East and Africa

Key Inclusions of the market model are:

The coronary stents market research report includes an insightful review of the key industry trends.

  • The coronary stents market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
  • The report also includes market-level data on units, average selling prices, and market values.

Regional, country, and global coronary stents market insights:

  • The coronary stents market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • Coronary stents market SWOT analysis.
  • The report provides trends and Coronary stents market competitive dynamics.

Buy the Full Report to Know More About the Coronary Stents Market Share, Download a Free Report Sample

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies Covered: Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina GmbH, Vascular Concepts Ltd, and Others.

Countries Covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.


  • Extensive coverage of the coronary stents market under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of the coronary stents market and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Understand the COVID-19 impact on coronary stents.
  • Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving coronary stents.
  • Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
  • Formulate effective sales and marketing strategies with a detailed evaluation of coronary stents market share by company. Identify strong competitors and create winning strategies to stand out in the global coronary stents market.
  • Track regional coronary stents market sales as well as country-specific transactions from 2015-2033.
  • Organize your sales and marketing efforts by identifying the global coronary stents market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.

Boston Scientific Corp
Abbott Laboratories
Medtronic Plc
Biotronik SE & Co KG
Lepu Medical Technology (Beijing) Co Ltd
B. Braun Melsungen AG
MicroPort Scientific Corp
Sahajanand Medical Technologies Pvt Ltd
Meril Life Sciences Pvt Ltd
Translumina Therapeutics LLP

Frequently asked questions

Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 standard reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 in real time.

  • Access a live Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.